Back Data Infrastructure / Commodities

ECL: Liquid Cooling Update & IR Takeaways — Catalysts Bringing AI Capex Exposure Into Focus

Published on May 22, 2026

∙ Download the PDF Report

By

Dauvin Peterson

ECL was among our primary liquid cooling beneficiaries (The Next AI Backlog Story – Liquid Cooling, 5/6/26). The stock has underperformed the liquid cooling peer group YTD, weighed down by Iran-related oil price inflation. We believe closing of the CoolIT acquisition in Q3 and potential oil price relief are the two positive catalysts that redirect investor focus to ECL’s growing exposure to liquid cooling and AI capex.

CoolIT acquisition: On track for Q3 close:

On May 15th the Canadian Competition Bureau issued an Advanced Ruling Certificate (ARC) — an important regulatory go-ahead step. Subsequently, on May 19th ECL announced a $5B bond offering, signaling the deal is in final stages to close.

Highlights from a conversation with IR:

Combined offering: ECL’s $1.5B high-growth tech exposure scales materially post-close. The combined platform pairs ultrapure water and 3D Trasar monitoring with CoolIT’s cooling stack (CDU, manifolds, cold plates), plus proprietary coolant fluids and 6-second operational diagnostics. Management views direct-to-chip cooling as a 3–5× revenue lift versus legacy air-cooled data center architecture.

Go-to-market readiness: Management indicated they are prepared to be in the market with a combined offering immediately upon close. CoolIT is actively engaged with chip developers on next-generation designs — a competitive validation.

Semiconductor fabrication: Ovivo combined with ECL’s core water business creates a credible greenfield and retrofit go-to-market for fabs. Pilot projects are demonstrating water recycling improvement from 5% to 80%, with purity gains that lift chip yields. Greenfield fab wins would represent $100M+ contracts with multi-year annuity revenue.

Macro / Iran war: The cost picture is more manageable than the 2022 Ukraine shock — raw material basket inflation is running +9% versus 50%+ previously, with significantly less supply chain disruption. ECL has also restructured its surcharge mechanism to compress the time to margin neutrality from 18 months to 1–2 quarters.

Life sciences: Customer wins are driving near-term momentum. AI’s impact on ECL here is not yet direct, but an acceleration in drug discovery could benefit ECL through its higher exposure to commercialized products.

The stock has been a notable laggard among liquid cooling/thermal management names; shares are down YTD despite growing exposure to AI capex.

A graph on a screen

AI-generated content may be incorrect.

Source: Bloomberg

The relative P/E premium of ECL to the S&P has compressed to a 10-year low of 34%, reflecting the Iran War and resulting oil price increase overhang. The company has demonstrated confidence in managing cost inflation however macro headline relief from the opening of the Straits would be a positive.

A graph with yellow lines

AI-generated content may be incorrect.

Source: Bloomberg

In summary, while ECL is not currently recognized for its growing AI capex exposure, this is expected to change once CoolIT closes. The acquisition gives ECL sizable exposure to two market growth segments tied to AI; AI factories via liquid cooling and semiconductor fabrication via water management.

Please reach out if you’d like to discuss further.

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.